Healthcare

January 15, 2021 The following alert is from The Council’s government affairs team. Yesterday afternoon, the incoming Biden Administration released the outline of a $1.9 trillion COVID-19 relief package that

The Council’s initial thoughts on the potential brokerage impact of potential full upcoming Democratic control of the executive and legislative branches.

After nearly a week of threats to veto the $2.3 trillion omnibus/relief bill, President Trump signed it into law.

Federal government funding runs out at midnight tonight, and is unclear whether the House and the Senate can act on a catch-all funding measure as well as pandemic relief.

Much is at risk, including a revised PPP plan, as well as potential major provisions on surprise medical billing.

The Trump Administration issued final rules (initially proposed in 2018 and 2019) aimed at lowering Medicare drug costs and reducing regulatory burdens in the Medicare program.

The U.S. Congress is moving fast on phase III of a COVID-response bill known as the Coronavirus Aid, Relief, and Economic Security Act (the amended CARES Act).

An update on the Federal government’s response to the COVID-19 pandemic from our partners at Steptoe & Johnson.

The IRS announced that high-deductible health plans (HDHPs) may cover COVID-19 testing and treatment pre-deductible.

Experts seem to be saying many will be contested.